Author

R. S. Hardy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. R. Clark· 1 shared A. Rauch· 1 shared B. Hartmann· 1 shared C. M. Gorvin· 1 shared C. Martin· 1 shared C. S. Martin· 1 shared J. B. Olesen· 1 shared J. D. O'Neil· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. R. Clark

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The glucocorticoid dexamethasone impairs the expression of anti-viral mediators in activated macrophages by inhibiting both expression and function of interferon beta.

J. D. O'Neil, O. O. Bolimowska, S. A. Clayton, T. Tang, K. K. Daley, S. Lara-Reyna, J. Warner, C. S. Martin, R. Y. Mahida, R. S. Hardy, S. Arthur, A. R. Clark

This study shows dexamethasone inhibits antiviral gene expression in macrophages by suppressing IFNβ expression and downstream interferon-regulated genes.

bioRxiv · May 3, 2023 · PreprintImmunology

GIP receptor reduces osteoclast activity and improves osteoblast survival by activating multiple signaling pathways

M. S. Hansen, K. Soe, L. L. Christensen, P. Fernandez-Guerra, N. W. Hansen, R. A. Wyatt, C. Martin, R. S. Hardy, T. L. Anderson, J. B. Olesen, S. Overgaard, B. Hartmann, M. M. Rosenkilde, M. Kassem, A. Rauch, , M. Frost

This study shows GIP reduces osteoclast activity and improves osteoblast survival through multiple signaling pathways, suggesting GIPR agonism could treat osteoporosis.

bioRxiv · Jul 2, 2022Cell Biology